May Hill Capital’s AstraZeneca AZN Stock Holding History

May Hill Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$532K	Sell	2,697 -3,297	-55%	-$636K	0.13%	105
2025 Q4	$1.1M	Buy	5,994 +1,080	+22%	+$189K	0.3%	58
2025 Q3	$754K	Buy	4,914 +317	+7%	+$48K	0.22%	73
2025 Q2	$642K	Buy	4,597 +324	+8%	+$45.4K	0.21%	78
2025 Q1	$628K	Buy	4,273 +2,010	+89%	+$291K	0.24%	65
2024 Q4	$296K	Buy	+2,263	New	+$317K	0.11%	116

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

May Hill Capital's AZN Position: Q1 2026 in Review

May Hill Capital reduced its AstraZeneca (AZN) stake by 55% in Q1 2026, selling an estimated $636K and leaving 2,697 shares worth $532K. The position accounts for 0.13% of the portfolio, ranked #105.

May Hill Capital first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.1M in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

May Hill Capital held 2,697 shares of AstraZeneca worth $532K as of Q1 2026.
May Hill Capital sold 3,297 AstraZeneca shares in Q1 2026, an estimated $636K.
AstraZeneca made up 0.13% of May Hill Capital's portfolio in Q1 2026, its #105 holding.
May Hill Capital first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
May Hill Capital's AstraZeneca position peaked at $1.1M in Q4 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.